Insulin Therapy for Type 1 Diabetes Explained

TL;DR

• Insulin isn’t optional in type 1 diabetes. The pancreas stops making it, so no diet, supplement, or fasting protocol replaces it. Therapy starts at diagnosis and continues for life.
• Most regimens are basal-bolus: one long-acting insulin for background coverage plus rapid-acting insulin at meals, delivered by pen injections or an insulin pump.
• Starting doses are usually estimated from body weight, commonly around 0.4 to 0.5 units per kilogram per day, split roughly half basal and half bolus, then adjusted using glucose readings and carb counting.
• Budget by units, not by vials. A 10 mL U-100 vial holds 1,000 units but gets discarded 28 days after opening, so a 35-unit-a-day regimen typically burns one vial of each insulin per month even with insulin left inside.
• Hypoglycemia is the main day-to-day safety risk, which is why a CGM, a glucagon rescue kit, and written correction rules belong in the plan from week one, not month six.

The hardest part of a new type 1 diagnosis usually isn’t the needles. It’s the volume of decisions landing on you in the first two weeks: which insulin, how many injections, pen or pump, carb ratios, what any of it will cost. Insulin therapy for type 1 diabetes is the lifelong replacement of a hormone the pancreas no longer makes, because the immune system destroyed the beta cells that produced it. There’s no workaround. Here’s how the regimens actually work, what the math looks like, and where people get tripped up.

Thank you for reading this post, don't forget to subscribe!

Table of Contents

• What is type 1 diabetes, and why does it always require insulin?
• Is insulin therapy really required for type 1 diabetes?
• What is the best insulin treatment for type 1 diabetes?
• How many times a day does a type 1 diabetic need insulin?
• Insulin pump versus injections: which actually works better?
• What does insulin therapy actually cost, and does insurance cover it?
• How do you manage hypoglycemia risk and long-term complications?
• Where this fits if you’re also managing broader metabolic or energy issues
• Frequently asked questions

What is type 1 diabetes, and why does it always require insulin?

Type 1 diabetes is an autoimmune condition where the immune system destroys the insulin-producing beta cells in the pancreas. Without insulin, glucose can’t move from the bloodstream into cells, so it builds up in the blood while the body starves for fuel.

That’s the real difference between type 1 and type 2 diabetes. In type 1, production stops almost completely, usually over months to a few years. In type 2, the pancreas keeps making insulin but cells stop responding to it well, and many people produce their own insulin for years. The treatment paths split sharply because of that. Type 2 can often be managed with lifestyle changes, metformin, or GLP-1 medications long before insulin enters the picture. Type 1 needs insulin on day one.

Type 1 diabetes symptoms come on fast, often over days or a couple of weeks: relentless thirst, constant urination, unexplained weight loss, fatigue, blurred vision. Further along, you see fruity-smelling breath, nausea, and vomiting from diabetic ketoacidosis (DKA). The CDC makes the case that catching and treating type 1 before DKA develops improves outcomes and reduces hospitalizations, which is why fast diagnosis and immediate insulin matter so much (CDC).

One line answer to what is type 1 diabetes: an autoimmune disease that permanently shuts off the body’s insulin supply. Insulin therapy isn’t one option among several. It’s the treatment.

Is insulin therapy really required for type 1 diabetes?

Yes, for everyone, without exception. This myth deserves blunt correction because it circulates constantly. Spend ten minutes in wellness corners of the internet and you’ll find claims that strict low-carb eating, extended fasting, or some supplement protocol lets a person with type 1 “manage without insulin.” It’s false and it kills people. Strip away insulin and the body burns fat for fuel, floods with ketones, and slides into diabetic ketoacidosis over hours to days.

The myth sticks around for three reasons:

• Confusion with type 2 diabetes, where insulin is sometimes added late and occasionally scaled back when other treatments take hold. That flexibility doesn’t exist in type 1.
• The honeymoon phase. For weeks to months after diagnosis, remaining beta cells still produce a trickle of insulin, and injected doses drop sharply. People read that as recovery. It isn’t. Beta cell function keeps declining until it’s gone, and the dose climbs back up.
• Survivorship bias. The person who skipped doses for a weekend and felt fine posts about it. The person who woke up in the ICU with DKA doesn’t write the follow-up thread.

The UpToDate patient guide is direct on this point: insulin is not optional, and even short gaps in dosing create real ketoacidosis risk (UpToDate).

If you’re sorting out fatigue and energy crashes and aren’t sure whether blood sugar, hormones, or something else is driving them, our guide on low cortisol symptoms and what actually helps covers how adrenal and metabolic problems produce overlapping symptoms that get misattributed.

What is the best insulin treatment for type 1 diabetes?

There’s no single best regimen. The right one depends on your schedule, how tightly you want to run your glucose, what you can afford, and how you feel about injections. What most good regimens share is a basal-bolus structure: long-acting insulin underneath, rapid-acting insulin on top at meals. Reviews of insulin therapy in adults with type 1 consistently favor basal-bolus delivery, by injection or pump, over older fixed-dose approaches, mainly because it imitates how a working pancreas releases insulin (PMC).

Types of insulin for type 1 diabetes break down roughly like this:

• Rapid-acting (lispro, aspart, glulisine): starts working in about 10 to 20 minutes, peaks around the one to two hour mark, taken with meals to cover the carbs you’re about to eat.
• Short-acting (regular): older, onset closer to 30 minutes, which means dosing further ahead of the meal. Still cheap and still widely used by people paying cash.
• Long-acting basal (glargine, detemir): a flat background level lasting roughly 20 to 24 hours, dosed once or sometimes twice daily.
• Ultra-long-acting (degludec): stretches past 36 hours, which forgives a dose taken several hours off schedule. Useful for shift workers and anyone whose bedtime moves around.
• Premixed: rapid plus intermediate in one pen. Simpler, far less flexible, and uncommon in type 1 for that reason.

A typical insulin regimen for type 1 diabetes in an adult is one basal injection at bedtime or in the morning, plus three or more rapid-acting doses at meals, with corrections layered in when a reading runs high. Modern pens take most of the drama out of it. They come prefilled, dial in single units, and the injection itself is a few seconds with a needle short enough that most people barely register it.

Pro tip: ask for written, numbered correction rules the same week you’re diagnosed, not three months later. You want a card that says “if your reading is X, take Y units” in plain numbers. Verbal instructions evaporate the moment you’re standing in a restaurant at 220 mg/dL trying to decide. Ask for the sick-day rules at the same visit, because that’s the scenario that actually sends people to the hospital.

The American Diabetes Association’s guide to insulin routines is a solid plain-language reference on how basal-bolus dosing gets structured (ADA).

How many times a day does a type 1 diabetic need insulin?

Most people on multiple daily injections dose 4 to 6 times a day: one basal injection, sometimes two depending on the insulin, plus a rapid-acting bolus with every meal or carb-containing snack. Pump users technically receive insulin around the clock, since the pump drips out micro-doses of basal every few minutes, with the wearer triggering boluses at meals. In practice that’s 3 to 5 active dosing decisions a day rather than discrete shots.

Calculating insulin dose starts with a total daily dose estimate and gets refined from there. The framework clinicians commonly start from:

1. Estimate total daily dose (TDD). A frequent starting point for a newly diagnosed adult is 0.4 to 0.5 units per kilogram of body weight per day. Lower during a partial honeymoon phase, higher with significant insulin resistance.
   • Example: a 70 kg adult (about 154 lb) at 0.5 units/kg = 35 units per day.
2. Split about 50/50 between basal and bolus. That’s roughly 17 to 18 units of basal once daily and 17 to 18 units of rapid-acting spread across meals.
3. Divide the bolus portion using a carb ratio. Eighteen units over three meals is about 6 units per meal to start, then refined to an insulin-to-carb ratio such as 1 unit per 10 grams of carbohydrate, plus a correction factor for out-of-range readings.

Same 70 kg example at a 1:10 ratio: a meal with 50 grams of carbs means 50 ÷ 10 = 5 units, nudged up or down based on the pre-meal reading. Re-run it with your own ratio and your own plate.

This is illustration, not prescription. Real starting doses and ratios get set by a physician using weight, labs, activity, and the first few weeks of glucose logs. The Medscape clinical reference on type 1 diabetes treatment lays out similar initial dosing frameworks, with adjustments made every few days off those logs (Medscape).

Insulin pump versus injections: which actually works better?

Neither wins outright. Pumps tend to buy tighter control and hour-by-hour flexibility; injections buy simplicity and a far lower entry cost. How they compare in daily life:

Pro tip: if you’re newly diagnosed, spend the first 3 to 6 months on injections. Carb counting and manual correction are skills, and a pump amplifies whatever you’ve learned, including the mistakes. People who come to a pump already knowing their carb ratio dial in good settings in a week. People who skip that step spend two months fighting the device.

What does insulin therapy actually cost, and does insurance cover it?

Costs swing enormously by insurance, insulin type, and pump versus pens, so instead of quoting a range at you, here’s how to build your own number before you ever call the pharmacy.

Step 1: convert your daily dose into monthly units. Using the 35-units-a-day example: 35 × 30 = 1,050 units per month, split about 525 basal and 525 bolus.

Step 2: convert units into containers. A 10 mL U-100 vial holds 1,000 units. A standard pen holds 300. On paper, 525 units is half a vial of each. In practice, insulin gets discarded 28 days after it’s opened, so you open a fresh vial of each insulin every month and throw away what’s left. Budget one vial of each per month at that dose, not half.

Step 3: multiply by your actual price. If a vial quotes at $120, that’s 2 × $120 = $240 a month for insulin alone, before pen needles or test strips.

Step 4: add the hardware. CGM sensors last 10 to 14 days depending on the brand, so figure 2 to 3 sensors a month. Pump infusion sets get changed every 2 to 3 days, so 10 to 15 sets a month plus reservoirs.

Where the number moves:

• Older human insulins (NPH and regular) cost a fraction of the newer analogs and are available over the counter in most states. They’re less forgiving to dose and demand stricter meal timing, but they’re a legitimate bridge if you’re uninsured between jobs.
• Manufacturer copay cards can gut the price for people with commercial insurance, often down to a flat monthly amount regardless of list price. They generally exclude anyone on Medicare or Medicaid, which is the cruel part.
• Vials plus syringes almost always beat pens on cost per unit. If you’re paying cash, that’s the first switch to discuss.
• Pump approval requires paperwork, typically A1C history and documentation of a stretch on multiple daily injections, which is one more reason the MDI-first path makes sense.

Pro tip: call your insurer and ask about your “durable medical equipment” benefit and your “pharmacy benefit” as two separate questions. Pumps and CGMs often bill under DME while insulin bills under pharmacy, and a frontline rep answering about one will confidently give you wrong information about the other. Get a reference number for the call.

How do you manage hypoglycemia risk and long-term complications?

Hypoglycemia, generally a reading under 70 mg/dL, is the most immediate risk of insulin therapy, and handling it well is what separates people who feel in control from people who dose nervously and run high on purpose. On the other end, years of elevated glucose drive nerve damage, kidney disease, and retinal damage. Both directions matter.

What actually reduces risk:

• Wear a CGM if you can get one. The trend arrow is the real feature. Knowing you’re at 95 and falling fast is a different decision than knowing you’re at 95.
• Stash fast glucose in four places: nightstand, bag, car, desk. Glucose tabs or juice, not chocolate, which absorbs too slowly to fix a 54.
• Carry a glucagon rescue kit, and show someone how to use it. Nasal versions are far easier for a panicked bystander than the old mix-and-draw kits.
• Review patterns monthly, not just after a scare. Recurring 3 a.m. lows or a 4 p.m. spike almost always trace to one fixable thing: too much basal, a carb ratio that’s off at one meal, or bolusing at the wrong moment relative to eating.
• Keep A1C and screening appointments on schedule, typically A1C every 3 to 6 months and annual eye and kidney checks. Early retinal and kidney changes are manageable. Late ones often aren’t.

One myth to kill here: insulin doesn’t cause diabetes complications. Unmanaged high blood sugar does. Plenty of people quietly under-dose because they’re worried about weight gain or “taking too much insulin,” and that choice raises complication risk by parking glucose in the 200s. Matching the dose to the actual need is the goal, not minimizing the number.

Where this fits if you’re also managing broader metabolic or energy issues

Type 1 diabetes management belongs with an endocrinologist or your primary care physician. It’s a specialized lane, and a longevity or hormone-focused telehealth practice shouldn’t be handling your insulin dosing. Be skeptical of any online clinic that offers to.

That said, plenty of people on insulin are also dealing with flattened energy, sleep that never feels restorative, or hormone shifts that get waved off as “just the diabetes” without anyone checking. If that’s where you are, know how to vet who you’re talking to. Our breakdown on how to choose a legit telehealth longevity clinic covers the red flags. YOURx Health’s founder built the practice out of his own experience managing a chronic condition, which is why the about page and the health hub lean toward physician-guided specifics instead of generic wellness copy. Hold your diabetes care team to that same standard.

Frequently asked questions

Can type 1 diabetes be diagnosed in adults, or is it only a childhood disease?

It can start at any age. Adult-onset type 1, sometimes called latent autoimmune diabetes in adults (LADA), progresses more slowly than classic childhood-onset type 1 and is routinely misdiagnosed as type 2 at first. If you’re a lean adult whose “type 2” isn’t responding to oral medications, ask about antibody testing and C-peptide.

Does an insulin regimen need to change over time?

Yes. Insulin needs shift with weight, activity, illness, stress, aging, and hormonal changes including puberty, pregnancy, and menopause. Ratios that worked for three years can stop working in a month. Most people on a stable regimen still review carb ratios and correction factors with their physician once or twice a year, and sooner if the glucose logs start drifting.

Is there any version of type 1 diabetes treatment that doesn’t involve insulin at all?

No. The underlying problem is a pancreas that can’t make insulin, so nothing standard replaces it. Adjunct medications like pramlintide are sometimes added to smooth post-meal spikes, but they’re additions, not substitutes. Beta cell transplants and immunotherapies that might delay or reduce insulin dependence are still research or highly specialized care, not something you’ll be offered at a routine appointment.

Start with one thing this week: write out your current total daily dose, multiply by 30, and divide by 1,000. That tells you how many vials you burn through a month and gives you a real number to take into your next call with your insurer or your endocrinologist.